Ginwa Enterprise Group Inc

Chart & Performance

D1W1MN

P/E

114.31

P/S

3.27

EPS

0.04

Div Yield, %

0.64%

Shrs. gr., 5y

-0.22%

Rev. gr., 5y

-4.03%

Revenues

544m

-7.07%

Net income

16m

-79.12%

CFO

25m

+128.07%

Dividend

Jun 20, 20250.03 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Ginwa Enterprise (Group) Inc. is a pharmaceutical company that specializes in the research, development, manufacturing, and commercialization of traditional Chinese, biological, and chemical medicines within China. The company's diverse product line encompasses treatments for a broad spectrum of medical conditions, including those related to orthopedics, immune system function, pediatric care, infectious diseases (such as antibiotics and antivirals), digestive health, gynecological issues, and cardiovascular ailments, as well as offerings for fever and pain relief. These medications are distributed in various common forms, specifically capsules, powders, and tablets. Ginwa Enterprise (Group) Inc. maintains its headquarters in Xi'an, China.

URL

http://www.ginwa.com.cn/

IPO date

Jun 12, 1997

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT